Clinical characteristics of ceftriaxone plus metronidazole in complicated intra-abdominal infection

Jung Min Bae1

  • 1Department of Surgery, Yeungnam University College of Medicine, Daegu, Korea.

Abstract

Insights

Ceftriaxone plus metronidazole regimen (CMR) efficacy in complicated intra-abdominal infections (c-IAI) is linked to low albumin and tachycardia. Patients with these factors may need additional antibiotic treatment plans for better outcomes.

Area of Science:

  • Infectious Diseases
  • Clinical Pharmacology
  • Surgical Infections

Background:

  • Complicated intra-abdominal infections (c-IAI), including secondary peritonitis, are initially treated with empirical antibiotics.
  • Ceftriaxone plus metronidazole regimen (CMR) is a common empirical choice, but its clinical efficacy and failure predictors remain unclear.
  • Understanding factors influencing CMR success is crucial for optimizing treatment strategies in c-IAI.

Purpose of the Study:

  • To retrospectively evaluate the clinical efficacy of the ceftriaxone plus metronidazole regimen (CMR) in patients with complicated intra-abdominal infections (c-IAI).
  • To identify clinical characteristics associated with the success or failure of CMR in treating secondary peritonitis.

Main Methods:

  • Retrospective analysis of 114 patients diagnosed with secondary peritonitis between 2009 and 2013.
  • Collected clinical data included albumin levels, vital signs, demographics, comorbidities, and APACHE II scores.
  • Univariate and multivariate analyses were performed to identify predictors of CMR treatment outcomes.

Main Results:

  • Low preoperative albumin and preoperative tachycardia were significantly associated with CMR treatment failure in both univariate and multivariate analyses.
  • Old age was also associated with treatment failure in the univariate analysis.
  • These findings highlight specific patient factors impacting the effectiveness of empirical CMR.

Conclusions:

  • Patients receiving CMR for c-IAI with low albumin and tachycardia may require adjusted or additional antibiotic therapy.
  • Further well-designed prospective studies are needed to confirm these findings and guide the selection of optimal empirical antibiotic regimens for c-IAI.

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
402
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
60
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
675
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.6K
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
1.1K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
550